Fezolinetant represents a significant advancement in the non-hormonal options for managing VMS associated with menopause. This module provides a summary of clinical evidence to support clinicians in identifying patients who are most likely to benefit from fezolinetant, enabling more personalized treatment options for women with VMS.
Identifying the Right Patients for Fezolinetant Therapy
CAN-eng
$0
free
Unaccredited
6 min
Women's Health
0 Credits
Course Description
Course Details
Expiry Date: 2026-10-04
Professions: Physician
Faculty
Accreditation
Learning Objective(s)
After viewing this microlearning, participants will be better able to:
- Identify patients that may benefit the most from fezolinetant therapy